Ingredient Dictionary

HYDROGENATED ROSIN

How much products actually contain

No product states its amount yet.

Of the products containing it, 4 list it before the 1% line and 0 after it (usually 1% or less).

Products using this ingredient

4 of 4 confirmed · likeliest to carry enough first

Definition

Rosin, hydrogenated

Cosmetic roles

Leaves a thin film where appliedFILM FORMINGGives the product a scentPERFUMINGAdjusts thicknessVISCOSITY CONTROLLING

Safety & regulatory references

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

More data — names, identifiers, properties, test records, literature

Official labels & definitions

JCIA labelling name 水添ロジン: 本品は、ロジン（＊）を水素添加したものである。

Source: JCIA labelling names (Japan)

Names & identifiers

HYDROGENATED ROSININCI하이드로제네이티드로진Korean label name (MFDS standard)Rosin, hydrogenatedSynonym水添ロジンJapanese labelling name

CAS No.chemical registry number: 65997-06-0
EC No.EU chemical inventory number: 266-041-3
DTXSIDUS EPA chemical ID: DTXSID0028294

Measured properties

Appearance: solid
Melting/freezing point: 75 ℃
Flash point: 203 ℃
Relative density: 1.05

Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.

Source: KOSHA safety data sheets (Korea)

What products actually use it for

What the 45 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

Adhesion/cohesion promoter20
Fragrance11
Plasticizer4
Lubricating agent2
Pigment2
Processing aids not otherwise specified1
Monomers1
Film former1

3 other uses

Viscosity modifier1
Binder1
Surface modifier1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

14 skin studies and 3 eye studies are on record.

Classed as highly irritating1Classed as low22

The studies disagree (the most common conclusion covers 4%), so they do not establish that this ingredient is irritating. These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 17 studies

Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: standard Draize method equivalent or similar to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · equivalent or similar to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
High Frequency of Sensitization
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Skin sensitisation - category 1
Skin Sensitization · Screening
Ambiguous
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Category 6.5B (Category 1)
Skin Sensitization · Read Across
Category 6.3B (Category 3)
Skin Irritation · Read Across
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to EU Method B.6 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) according to EU Method B.6 (Skin Sensitisation)
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
Severe Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to